Halozyme Reports First Quarter 2015 Financial Results

Go back to Halozyme Reports First Quarter 2015 Financial Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 111.45 -1 (0.89%)
Previous Close $112.45    52 Week High $18.39 
Open $112.80    52 Week Low $6.96 
Day High $113.47    P/E N/A 
Day Low $111.05    EPS $-0.58 
Volume 2,925,661